Sign in

CIK 0001815442

  • Large accelerated filer

Kymera Therapeutics, Inc.

Sign in to watch
Ticker
KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812992166
Phone
+1 857-285-5314
Business address
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
Former names
Kymera Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,158,214
in 2 filings, $3.4M under 10b5-1 plans

Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 68 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-26 BVF PARTNERS L P/IL Director Purchase +90,372 $14.21 $1.3M 1,601,575
2022-05-26 BVF PARTNERS L P/IL Director Purchase +10,642 $14.21 $151K 227,414
2022-05-20 BVF PARTNERS L P/IL Director Purchase +5,883 $14.00 $82K 2,036,860
2022-05-20 BVF PARTNERS L P/IL Director Purchase +4,180 $14.00 $59K 1,511,203
2022-05-20 BVF PARTNERS L P/IL Director Purchase +37 $14.00 $518 216,772
2022-05-06 BVF PARTNERS L P/IL Director Purchase +55,210 $19.26 $1.1M 2,030,977
2022-05-06 BVF PARTNERS L P/IL Director Purchase +40,659 $19.26 $783K 1,507,023
2022-05-06 BVF PARTNERS L P/IL Director Purchase +4,131 $19.26 $80K 216,735
2022-05-05 BVF PARTNERS L P/IL Director Purchase +75,495 $19.60 $1.5M 1,975,767
2022-05-05 BVF PARTNERS L P/IL Director Purchase +70,439 $19.60 $1.4M 1,466,364
2022-05-05 BVF PARTNERS L P/IL Director Purchase +4,066 $19.60 $80K 212,604
2022-05-04 Gollob Jared Chief Medical Officer Exercise or conversion +10,208 $1.31 $13K 47,465
2022-05-04 Gollob Jared Chief Medical Officer Exercise or conversion +9,792 $2.08 $20K 57,257
2022-05-04 Gollob Jared Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −10,208 29,799
2022-05-04 Gollob Jared Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −9,792 109,020
2022-05-03 Mainolfi Nello Chief Executive Officer Exercise or conversion +20,000 $2.08 $42K 502,199
2022-05-03 Mainolfi Nello Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −20,000 46,424
2022-05-03 Jacobs Bruce N. Chief Financial Officer Exercise or conversion +20,000 $2.08 $42K 60,814
2022-05-03 Jacobs Bruce N. Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −20,000 159,899
2022-03-01 Mainolfi Nello Chief Executive Officer Grant or award · Stock Option (Right to Buy) +275,100 275,100

Page 38 of 41 · 810 trades